Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-12 3:09 pm Purchase | 2020-12-31 | 13G | Frequency Therapeutics, Inc. FREQ | FEDERATED HERMES INC. FHI | 34,636 5.130% | 34,636![]() (New Position) | Filing History |
2021-02-12 3:06 pm Purchase | 2020-12-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FEDERATED HERMES INC. FHI | 1,235,033 6.340% | 1,235,033![]() (New Position) | Filing History |
2021-02-12 3:01 pm Purchase | 2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 7,000,000 5.650% | 7,000,000![]() (New Position) | Filing History |
2021-02-12 2:59 pm Purchase | 2020-12-31 | 13G | BCLS Acquisition Corp. BLSA | FEDERATED HERMES INC. FHI | 1,000,000 5.420% | 1,000,000![]() (New Position) | Filing History |
2021-02-12 2:55 pm Purchase | 2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,225,883 6.790% | 3,225,883![]() (New Position) | Filing History |
2021-02-12 2:51 pm Purchase | 2020-12-31 | 13G | Akouos, Inc. AKUS | FEDERATED HERMES INC. FHI | 2,319,482 6.750% | 2,319,482![]() (New Position) | Filing History |
2021-02-12 1:18 pm Purchase | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | FEDERATED HERMES INC. FHI | 372,130 10.550% | 25,400![]() (+7.33%) | Filing History |
2021-02-12 1:17 pm Purchase | 2020-12-31 | 13G | aTyr Pharma, Inc. LIFE | FEDERATED HERMES INC. FHI | 1,615,000 15.860% | 1,019,928![]() (+171.40%) | Filing History |
2021-02-12 1:16 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 4,282,563 5.400% | 516,198![]() (+13.71%) | Filing History |
2021-02-12 1:16 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 2,447,000 12.830% | 1,010,000![]() (+70.29%) | Filing History |
2021-02-12 1:14 pm Unchanged | 2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS | FEDERATED HERMES INC. FHI | 260,417 7.570% | 0 (Unchanged) | Filing History |
2021-02-12 1:12 pm Purchase | 2020-12-31 | 13G | uniQure N.V. QURE | FEDERATED HERMES INC. FHI | 3,855,615 8.670% | 844,169![]() (+28.03%) | Filing History |
2021-02-12 1:06 pm Purchase | 2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 4,280,528 6.470% | 1,308,520![]() (+44.03%) | Filing History |
2021-02-12 1:04 pm Purchase | 2020-12-31 | 13G | ShotSpotter, Inc. SSTI | FEDERATED HERMES INC. FHI | 1,074,672 9.390% | 26,724![]() (+2.55%) | Filing History |
2021-02-12 12:59 pm Purchase | 2020-12-31 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 2,129,553 19.470% | 268,512![]() (+14.43%) | Filing History |
2021-02-12 12:57 pm Unchanged | 2020-12-31 | 13G | Rezolute, Inc. RZLT | FEDERATED HERMES INC. FHI | 1,259,122 14.990% | 0 (Unchanged) | Filing History |
2021-02-12 12:55 pm Purchase | 2020-12-31 | 13G | Quest Resource Holding Corporation QRHC | FEDERATED HERMES INC. FHI | 2,525,000 13.780% | 700,000![]() (+38.36%) | Filing History |
2021-02-12 12:50 pm Unchanged | 2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,201,275 22.520% | 0 (Unchanged) | Filing History |
2021-02-12 12:46 pm Unchanged | 2020-12-31 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 2,936,798 10.100% | 0 (Unchanged) | Filing History |
2021-02-12 12:37 pm Purchase | 2020-12-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 12,521,800 11.310% | 2,700,000![]() (+27.49%) | Filing History |